As costs continue to soar ever higher, AstraZeneca sees new HQ sticker price gyrate to $1.28B
AstraZeneca may have come a long ways in changing its fortunes on the R&D side of the business, but CEO Pascal Soriot’s 8-year-old dream of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
